{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:20:32Z","timestamp":1793643632131,"version":"4.5.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Interaction of genetic predispositions and environmental factors via epigenetic mechanisms have been hypothesized to play a central role in Panic Disorder (PD) aetiology and therapy. Cognitive Behavioral Therapy (CBT), including exposure interventions, belong to the most efficient treatments of PD although its biological mechanism of action remains unknown. For the first time, we explored the dynamics and magnitude of DNA-methylation and immune cell-type composition during CBT (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200938) and the therapeutic exposure intervention (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200921) to unravel their biological correlates and identify possible biomarkers of therapy success. We report transient regulation of the CD4\u2009+\u2009T-Cells, Natural Killers cells, Granulocytes during exposure and a significant change in the proportions of CD4\u2009+\u2009T cells, CD8\u2009+\u2009T cells and B-Cells and Granulocytes during therapy. In an epigenome-wide association study we identified cg01586609 located in a CpG island and annotated to the serotonin receptor 3\u2009A (HTR3A) to be differentially methylated during fear exposure and regulated at gene expression level with significant differences between remitters and non-remitters (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.028). We moreover report cg01699630 annotated to ARG1 to undergo long lasting methylation changes during therapy (paired t test, genome-wide adj.\n                    <jats:italic>p<\/jats:italic>\n                    value\u2009=\u20090.02). This study reports the first data-driven biological candidates for epigenetically mediated effects of acute fear exposure and CBT in PD patients. Our results provide evidence of changes in the serotonin receptor 3\u2009A methylation and expression during fear exposure associated with different long-term CBT trajectories and outcome, making it a possible candidate in the search of markers for therapy success. Finally, our results add to a growing body of evidence showing immune system changes associated with PD.\n                  <\/jats:p>","DOI":"10.1038\/s41398-022-01802-7","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T01:03:10Z","timestamp":1643677390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["DNA-methylation dynamics across short-term, exposure-containing CBT in patients with panic disorder"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-5866","authenticated-orcid":false,"given":"Sylvain","family":"Moser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6528-8947","authenticated-orcid":false,"given":"Jade","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7381-904X","authenticated-orcid":false,"given":"Darina","family":"Czamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2153-1121","authenticated-orcid":false,"given":"Jennifer","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"M\u00fcller-Myhsok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Erhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"1802_CR1","first-page":"3","volume":"66","author":"PT Ninan","year":"2005","unstructured":"Ninan PT, Dunlop BW. Neurobiology and etiology of panic disorder. J Clin Psychiatry. 2005;66:3\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1802_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.euroneuro.2005.04.006","volume":"15","author":"RD Goodwin","year":"2005","unstructured":"Goodwin RD, Faravelli C, Rosi S, Cosci F, Truglia E, De Graaf R, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005;15:435\u201343.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1802_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.euroneuro.2011.07.018","volume":"21","author":"HU Wittchen","year":"2011","unstructured":"Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, J\u00f6nsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655\u201379.","journal-title":"Eur Neuropsychopharmacol"},{"key":"1802_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/mpr.1359","volume":"21","author":"RC Kessler","year":"2012","unstructured":"Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21:169\u201384.","journal-title":"Int J Methods Psychiatr Res."},{"key":"1802_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1017\/S0033291709005625","volume":"40","author":"NM Batelaan","year":"2010","unstructured":"Batelaan NM, De Graaf R, Penninx BWJH, Van Balkom AJLM, Vollebergh WAM, Beekman ATF. The 2-year prognosis of panic episodes in the general population. Psychol Med 2010;40:147\u201357.","journal-title":"Psychol Med"},{"key":"1802_CR6","doi-asserted-by":"crossref","unstructured":"Hendriks SM, Spijker J, Licht CMM, Hardeveld F, de Graaf R, Batelaan NM, et al. Long-term disability in anxiety disorders. BMC Psychiatry. 2016;16:248.","DOI":"10.1186\/s12888-016-0946-y"},{"key":"1802_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/da.22728","volume":"35","author":"JK Carpenter","year":"2018","unstructured":"Carpenter JK, Andrews LA, Witcraft SM, Powers MB, Smits JAJ, Hofmann SG. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018;35:502\u201314.","journal-title":"Depress Anxiety"},{"key":"1802_CR8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/13651501.2012.667114","volume":"16","author":"B Bandelow","year":"2012","unstructured":"Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pr Int J Psychiatry Clin Pr. 2012;16:77\u201384.","journal-title":"Int J Psychiatry Clin Pr Int J Psychiatry Clin Pr"},{"key":"1802_CR9","doi-asserted-by":"crossref","unstructured":"Deckert J, Erhardt A Predicting treatment outcome for anxiety disorders with or without comorbid depression using clinical, imaging and (epi)genetic data. Curr Opin Psychiatry. 2019;32:1\u20136.","DOI":"10.1097\/YCO.0000000000000468"},{"issue":"Sep","key":"1802_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jamapsychiatry.2019.1119","volume":"76","author":"SM Meier","year":"2019","unstructured":"Meier SM, Trontti K, Purves KL, Als TD, Grove J, Laine M, et al. Genetic Variants Associated With Anxiety and Stress-Related Disorders. JAMA Psychiatry. 2019;76(Sep):924.","journal-title":"JAMA Psychiatry"},{"key":"1802_CR11","doi-asserted-by":"crossref","unstructured":"Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS The structure of genetic and environmental risk factors for anxiety disorders in men and women. Arch Gen Psychiatry. 2005;62:182\u20139.","DOI":"10.1001\/archpsyc.62.2.182"},{"key":"1802_CR12","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.jmb.2019.10.021","volume":"432","author":"JF Kribelbauer","year":"2020","unstructured":"Kribelbauer JF, Lu XJ, Rohs R, Mann RS, Bussemaker HJ. Toward a mechanistic understanding of DNA methylation readout by transcription factors. J Mol Biol. 2020;432:1801\u201315. https:\/\/doi.org\/10.1016\/j.jmb.2019.10.021.","journal-title":"J Mol Biol"},{"key":"1802_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/83730","volume":"27","author":"L Jackson-grusby","year":"2001","unstructured":"Jackson-grusby L, Beard C, Possemato R, Tudor M, Fambrough D, Csankovszki G, et al. Loss of genomic methylation causes p53- dependent apoptosis and epigenetic deregulation. Nat Genet. 2001;27:31\u20139.","journal-title":"Nat Genet"},{"key":"1802_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-016-0307-1","volume":"9","author":"M Shimada-Sugimoto","year":"2017","unstructured":"Shimada-Sugimoto M, Otowa T, Miyagawa T, Umekage T, Kawamura Y, Bundo M, et al. Epigenome-wide association study of DNA methylation in panic disorder. Clin Epigenetics. 2017;9:1\u201311. https:\/\/doi.org\/10.1186\/s13148-016-0307-1.","journal-title":"Clin Epigenetics"},{"key":"1802_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/npp.2017.102","volume":"43","author":"RT Emeny","year":"2018","unstructured":"Emeny RT, Baumert J, Zannas AS, Kunze S, Wahl S, Iurato S, et al. Anxiety associated increased CpG methylation in the promoter of Asb1: a translational approach evidenced by epidemiological and clinical studies and a murine model. Neuropsychopharmacology. 2018;43:342\u201353.","journal-title":"Neuropsychopharmacology."},{"key":"1802_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-017-0026-1","volume":"7","author":"S Iurato","year":"2017","unstructured":"Iurato S, Carrillo-Roa T, Arloth J, Czamara D, Diener-H\u00f6lzl L, Lange J, et al. DNA methylation signatures in panic disorder. Transl Psychiatry. 2017;7:1\u201310. https:\/\/doi.org\/10.1038\/s41398-017-0026-1.","journal-title":"Transl Psychiatry"},{"key":"1802_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-020-00972-9","volume":"12","author":"CL Petersen","year":"2020","unstructured":"Petersen CL, Chen JQ, Salas LA, Christensen BC. Altered immune phenotype and DNA methylation in panic disorder. Clin Epigenetics. 2020;12:1\u201310. https:\/\/doi.org\/10.1186\/s13148-020-00972-9.","journal-title":"Clin Epigenetics"},{"key":"1802_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hup.470100605","volume":"10","author":"GI Perini","year":"1995","unstructured":"Perini GI, Zara M, Carraro C, Tosin C, Gava F, Santucci MG, et al. Psychoimmunoendocrine aspects of panic disorder. Hum Psychopharmacol Clin Exp. 1995;10:461\u20135.","journal-title":"Hum Psychopharmacol Clin Exp."},{"key":"1802_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0006-3223(97)00263-1","volume":"43","author":"MH Rapaport","year":"1998","unstructured":"Rapaport MH. Circulating lymphocyte phenotypic surface markers in anxiety disorder patients and normal volunteers. Biol Psychiatry. 1998;43:458\u201363.","journal-title":"Biol Psychiatry"},{"key":"1802_CR20","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0889-1591(02)00022-3","volume":"16","author":"SJ Schleifer","year":"2002","unstructured":"Schleifer SJ, Keller SE, Bartlett JA. Panic disorder and immunity: Few effects on circulating lymphocytes, mitogen response, and NK cell activity. Brain Behav Immun. 2002;16:698\u2013705. https:\/\/doi.org\/10.1016\/S0889-1591(02)00022-3.","journal-title":"Brain Behav Immun"},{"key":"1802_CR21","doi-asserted-by":"publisher","unstructured":"Ziegler C, Grundner-Culemann F, Schiele MA, Schlosser P, Kollert L, Mahr M, et al. The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study. Transl Psychiatry. 2019;9:314. Available from: https:\/\/doi.org\/10.1038\/s41398-019-0648-6.","DOI":"10.1038\/s41398-019-0648-6"},{"key":"1802_CR22","doi-asserted-by":"crossref","unstructured":"Martins J, Czamara D, Lange J, Dethloff F, Binder EB, Turck CW, et al. Exposure\u2010induced changes of plasma metabolome and gene expression in patients with panic disorder. Depress Anxiety. 2019;36:1173\u201381.","DOI":"10.1002\/da.22946"},{"key":"1802_CR23","unstructured":"Lang T, Helbig-Lang S, Westphal D, Gloster AT, Wittchen H-U Expositionsbasierte Therapie der Panikst\u00f6rung mit Agoraphobie. Expositionsbasierte Therapie der Panikst\u00f6rung mit Agoraphobie. Hogrefe Verlag; 2012."},{"key":"1802_CR24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1037\/pst0000365","volume":"58","author":"J Lange","year":"2021","unstructured":"Lange J, Goerigk S, Nowak K, Rosner R, Erhardt A. Attachment style change and working alliance in panic disorder patients treated with cognitive behavioral therapy. Psychotherapy. 2021;58:206\u201318.","journal-title":"Psychotherapy."},{"key":"1802_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50\u20135.","journal-title":"Br J Med Psychol"},{"key":"1802_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-5-1","volume":"5","author":"A Menke","year":"2012","unstructured":"Menke A, Rex-Haffner M, Klengel T, Binder EB, Mehta D. Peripheral blood gene expression: It all boils down to the RNA collection tubes. BMC Res Notes. 2012;5:1\u20138.","journal-title":"BMC Res Notes"},{"key":"1802_CR27","doi-asserted-by":"crossref","unstructured":"Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.","DOI":"10.1186\/1471-2105-13-86"},{"key":"1802_CR28","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1093\/bioinformatics\/bts545","volume":"28","author":"BS Pedersen","year":"2012","unstructured":"Pedersen BS, Schwartz DA, Yang IV, Kechris KJ. Comb-p: Software for combining, analyzing, grouping and correcting spatially correlated P-values. Bioinformatics. 2012;28:2986\u20138.","journal-title":"Bioinformatics."},{"key":"1802_CR29","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1093\/schbul\/sbu147","volume":"41","author":"H Kimura","year":"2015","unstructured":"Kimura H, Tsuboi D, Wang C, Kushima I, Koide T, Ikeda M, et al. Identification of rare, single-nucleotide mutations in NDE1 and their contributions to schizophrenia susceptibility. Schizophr Bull. 2015;41:744\u201353.","journal-title":"Schizophr Bull"},{"key":"1802_CR30","first-page":"1","volume":"2","author":"C Gavrilovici","year":"2021","unstructured":"Gavrilovici C, Jiang Y, Kiroski I, Sterley T-L, Vandal M, Bains J, et al. Behavioral deficits in mice with postnatal disruption of Ndel1 in forebrain excitatory neurons: implications for epilepsy and neuropsychiatric disorders. Cereb Cortex Commun. 2021;2:1\u201318.","journal-title":"Cereb Cortex Commun."},{"key":"1802_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.psychres.2011.01.023","volume":"189","author":"HJ Park","year":"2011","unstructured":"Park HJ, Kim JW, Lee SK, Kim SK, Park JK, Cho AR, et al. Association between the SLC6A12 gene and negative symptoms of schizophrenia in a Korean population. Psychiatry Res. 2011;189:478\u20139. https:\/\/doi.org\/10.1016\/j.psychres.2011.01.023.","journal-title":"Psychiatry Res"},{"key":"1802_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nn1812","volume":"10","author":"SJ Russo","year":"2007","unstructured":"Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, et al. IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci. 2007;10:93\u20139.","journal-title":"Nat Neurosci"},{"key":"1802_CR33","doi-asserted-by":"crossref","unstructured":"Asoglu M, Aslan M, Imre O, Kivrak Y, Akil O, Savik E, et al. Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder. Neuropsychiatr Dis Treat. 2016;12:2435\u201338.","DOI":"10.2147\/NDT.S111108"},{"key":"1802_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1055\/s-0040-1703422","volume":"11","author":"RS Ransing","year":"2020","unstructured":"Ransing RS, Gupta N, Agrawal G, Mahapatro N. Platelet and red blood cell indices in patients with panic disorder: a receiver operating characteristic analysis. J Neurosci Rural Pract. 2020;11:261\u20136.","journal-title":"J Neurosci Rural Pract."},{"key":"1802_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpsychores.2012.04.012","volume":"73","author":"R T\u00fckel","year":"2012","unstructured":"T\u00fckel R, Arslan BA, Ertekin BA, Ertekin E, Oflaz S, Ergen A, et al. Decreased IFN-\u03b3 and IL-12 levels in panic disorder. J Psychosom Res. 2012;73:63\u20137.","journal-title":"J Psychosom Res."},{"key":"1802_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.psyneuen.2012.05.008","volume":"37","author":"FS Dhabhar","year":"2012","unstructured":"Dhabhar FS, Malarkey WB, Neri E, McEwen BS. Stress-induced redistribution of immune cells-From barracks to boulevards to battlefields: a tale of three hormones - Curt Richter Award Winner. Psychoneuroendocrinology [Internet]. 2012;37:1345\u201368. Available from: https:\/\/doi.org\/10.1016\/j.psyneuen.2012.05.008.","journal-title":"Psychoneuroendocrinology [Internet]"},{"key":"1802_CR37","doi-asserted-by":"crossref","unstructured":"Dhabhar FS, Miller AH, McEwen BS, Spencer RL. Effects of stress on immune cell distribution. Dynamics and hormonal mechanisms. J Immunol. 1995;154:5511\u201327. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7730652.","DOI":"10.4049\/jimmunol.154.10.5511"},{"key":"1802_CR38","doi-asserted-by":"crossref","unstructured":"Hammer C, Cichon S, M\u00fchleisen TW, Haenisch B, Degenhardt F, Mattheisen M, et al. Replication of functional serotonin receptor type 3A and B variants in bipolar affective disorder: a European multicenter study. Transl Psychiatry. 2012;2:e103.","DOI":"10.1038\/tp.2012.30"},{"key":"1802_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/YPG.0b013e3282f02099","volume":"18","author":"N Mizuta","year":"2008","unstructured":"Mizuta N, Akiyoshi J, Sato A, Hanada H, Tanaka Y, Tsuru J, et al. Serotonin receptor 3A (HTR3A) gene is associated with personality traits, but not panic disorder. Psychiatr Genet. 2008;18:44.","journal-title":"Psychiatr Genet."},{"key":"1802_CR40","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1111\/bph.13857","volume":"174","author":"V Martin","year":"2017","unstructured":"Martin V, Riffaud A, Marday T, Brouillard C, Franc B, Tassin JP, et al. Response of Htr3a knockout mice to antidepressant treatment and chronic stress. Br J Pharmacol. 2017;174:2471\u201383.","journal-title":"Br J Pharmacol."},{"key":"1802_CR41","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1002\/da.20726","volume":"27","author":"JM Gatt","year":"2010","unstructured":"Gatt JM, Williams LM, Schofield PR, Dobson-Stone C, Paul RH, Grieve SM, et al. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety. 2010;27:752\u20139.","journal-title":"Depress Anxiety"},{"key":"1802_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/da.22406","volume":"33","author":"N Perroud","year":"2016","unstructured":"Perroud N, Zewdie S, Stenz L, Adouan W, Bavamian S, Prada P, et al. Methylation of serotonin receptor 3A in ADHD, borderline personality, and bipolar disorders: link with severity of the disorders and childhood maltreatment. Depress Anxiety. 2016;33:45\u201355.","journal-title":"Depress Anxiety"},{"key":"1802_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/339706a0","volume":"339","author":"V Derkach","year":"1989","unstructured":"Derkach V, Surprenant A, North RA. 5-HT3 receptors are membrane ion channels. Nature. 1989;339:706\u20139.","journal-title":"Nature."},{"key":"1802_CR44","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1176\/appi.ajp.157.4.493","volume":"157","author":"JM Gorman","year":"2000","unstructured":"Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157:493\u2013505.","journal-title":"Am J Psychiatry"},{"key":"1802_CR45","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/0959-4388(93)90122-F","volume":"3","author":"LH Tecott","year":"1993","unstructured":"Tecott LH, Julius D. A new wave of serotonin receptors. Curr Opin Neurobiol. 1993;3:310\u20135.","journal-title":"Curr Opin Neurobiol"},{"key":"1802_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-2999(02)02960-6","volume":"461","author":"SP Kelley","year":"2003","unstructured":"Kelley SP, Bratt AM, Hodge CW. Targeted gene deletion of the 5-HT3A receptor subunit produces an anxiolytic phenotype in mice. Eur J Pharmacol. 2003;461:19\u201325.","journal-title":"Eur J Pharmacol."},{"key":"1802_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/dneu.20853","volume":"71","author":"B Rudy","year":"2011","unstructured":"Rudy B, Fishell G, Lee S, Hjerling-Leffler J. Three groups of interneurons account for nearly 100% of neocortial GABAergic neurons. Dev Neurobiol. 2011;71:45\u201361.","journal-title":"Dev Neurobiol"},{"key":"1802_CR48","doi-asserted-by":"publisher","first-page":"7389","DOI":"10.1523\/JNEUROSCI.22-17-07389.2002","volume":"22","author":"I F\u00e9r\u00e9zou","year":"2002","unstructured":"F\u00e9r\u00e9zou I, Cauli B, Hill EL, Rossier J, Hamel E, Lambolez B. 5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide\/cholecystokinin interneurons. J Neurosci. 2002;22:7389\u201397.","journal-title":"J Neurosci."},{"key":"1802_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.31887\/DCNS.2011.13.4\/mkellner","volume":"13","author":"M Kellner","year":"2011","unstructured":"Kellner M. Experimental panic provocation in healthy man-a translational role in anti-panic drug development? Dialogues Clin Neurosci. 2011;13:485\u201393.","journal-title":"Dialogues Clin Neurosci."},{"key":"1802_CR50","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.neuron.2007.02.022","volume":"53","author":"CA Miller","year":"2007","unstructured":"Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron. 2007;53:857\u201369.","journal-title":"Neuron."},{"key":"1802_CR51","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s00213-017-4686-6","volume":"234","author":"SL Martin","year":"2017","unstructured":"Martin SL, Power A, Boyle Y, Anderson IM, Silverdale MA, Jones AKP. 5-HT modulation of pain perception in humans. Psychopharmacol (Berl). 2017;234:2929\u201339.","journal-title":"Psychopharmacol (Berl)."},{"key":"1802_CR52","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s002100000342","volume":"362","author":"M Br\u00fcss","year":"2000","unstructured":"Br\u00fcss M, Barann M, Hayer-Zillgen M, Eucker T, G\u00f6thert M, B\u00f6nisch H. Modified 5-HT(3A) receptor function by co-expression of alternatively spliced human 5-HT(3A) receptor isoforms. Naunyn Schmiedebergs Arch Pharmacol. 2000;362:392\u2013401.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1802_CR53","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.lab.2005.10.005","volume":"147","author":"CC Liew","year":"2006","unstructured":"Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006;147:126\u201332.","journal-title":"J Lab Clin Med."},{"key":"1802_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/ajmg.b.30272","volume":"141 B","author":"PF Sullivan","year":"2006","unstructured":"Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet - Neuropsychiatr Genet. 2006;141 B:261\u20138.","journal-title":"Am J Med Genet - Neuropsychiatr Genet."},{"key":"1802_CR55","doi-asserted-by":"crossref","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science (80-) [Internet]. 2020 Mar;367. Available from: https:\/\/www.science.org\/doi\/10.1126\/science.aay5947.","DOI":"10.1126\/science.aay5947"},{"key":"1802_CR56","first-page":"1","volume":"9","author":"H Ask","year":"2021","unstructured":"Ask H, Cheesman R, Jami ES, Levey DF, Purves KL, Weber H. Genetic contributions to anxiety disorders: where we are and where we are heading. Psychol Med. 2021;9:1\u201316.","journal-title":"Psychol Med."},{"key":"1802_CR57","doi-asserted-by":"crossref","unstructured":"Levey DF, Gelernter J, Polimanti R, Zhou H, Cheng Z, Aslan M, et al. Reproducible Genetic Risk Loci for Anxiety: Results From \u223c200,000 Participants in the Million Veteran Program. Am J Psychiatry. 2020;:appi.ajp.2019.1.","DOI":"10.1176\/appi.ajp.2019.19030256"},{"key":"1802_CR58","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41588-018-0151-7","volume":"50","author":"M Nagel","year":"2018","unstructured":"Nagel M, Jansen PR, Stringer S, Watanabe K, De Leeuw CA, Bryois J, et al. Meta-analysis of genome-wide association studies for neuroticism in 449,484 individuals identifies novel genetic loci and pathways. Nat Genet. 2018;50:920\u20137.","journal-title":"Nat Genet."},{"key":"1802_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"DM Howard","year":"2018","unstructured":"Howard DM, Adams MJ, Shirali M, Clarke TK, Marioni RE, Davies G, et al. Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways. Nat Commun. 2018;9:1\u201310.","journal-title":"Nat Commun."},{"key":"1802_CR60","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/mp.2016.259","volume":"23","author":"M Ikeda","year":"2018","unstructured":"Ikeda M, Takahashi A, Kamatani Y, Okahisa Y, Kunugi H, Mori N, et al. A genome-wide association study identifies two novel susceptibility loci and trans population polygenicity associated with bipolar disorder. Mol Psychiatry. 2018;23:639\u201347. https:\/\/doi.org\/10.1038\/mp.2016.259.","journal-title":"Mol Psychiatry"},{"key":"1802_CR61","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"S Ripke","year":"2014","unstructured":"Ripke S, Neale BM, Corvin A, Walters JTR, Farh KH, Holmans PA, et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","journal-title":"Nature."},{"key":"1802_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13148-019-0798-7","volume":"12","author":"C Snijders","year":"2020","unstructured":"Snijders C, Maihofer AX, Ratanatharathorn A, Baker DG, Boks MP, Geuze E, et al. Longitudinal epigenome-wide association studies of three male military cohorts reveal multiple CpG sites associated with post-traumatic stress disorder. Clin Epigenetics. 2020;12:1\u201313.","journal-title":"Clin Epigenetics"},{"key":"1802_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ccr.2014.07.028","volume":"26","author":"X Yang","year":"2014","unstructured":"Yang X, Han H, DeCarvalho DD, Lay FD, Jones PA, Liang G. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell [Internet]. 2014;26:577\u201390. Available from: https:\/\/doi.org\/10.1016\/j.ccr.2014.07.028.","journal-title":"Cancer Cell [Internet]"},{"key":"1802_CR64","doi-asserted-by":"publisher","unstructured":"Arechederra M, Daian F, Yim A, Bazai SK, Richelme S, Dono R, et al. Hypermethylation of gene body CpG islands predicts high dosage of functional oncogenes in liver cancer. Nat Commun. 2018;9. Available from: https:\/\/doi.org\/10.1038\/s41467-018-05550-5.","DOI":"10.1038\/s41467-018-05550-5"},{"key":"1802_CR65","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/humu.23545","volume":"39","author":"C Diez-Fernandez","year":"2018","unstructured":"Diez-Fernandez C, R\u00fcfenacht V, Gemperle C, Fingerhut R, H\u00e4berle J. Mutations and common variants in the human arginase 1 (ARG1) gene: Impact on patients, diagnostics, and protein structure considerations. Hum Mutat. 2018;39:1029\u201350.","journal-title":"Hum Mutat."},{"key":"1802_CR66","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1111\/febs.15715","volume":"288","author":"M Kieler","year":"2021","unstructured":"Kieler M, Hofmann M, Schabbauer G. More than just protein building blocks: How amino acids and related metabolic pathways fuel macrophage polarization. FEBS J. 2021;288:3694\u2013714.","journal-title":"FEBS J"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01802-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01802-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T05:59:28Z","timestamp":1674626368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01802-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1802"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-01802-7","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"10 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}